Graphic Packaging Holding Co (GPK) · Nov 3, 2026 · Earnings
Beat — Adj. EPS $0.23 vs ~$0.22 consensus; sales $2.192B vs ~$2.17B
Graphic Packaging’s third-quarter earnings narrowly beat expectations on revenue and adjusted EPS, but inflation drove a sharp margin decline and higher leverage.
Graphic Packaging is a heavily leveraged consumer-packaging manufacturer trying to rebuild margins through cost cuts, productivity gains, pricing and innovation while end-market volume remains subdued. Its broader challenge is not demand collapse but converting modest volume growth into profit while absorbing commodity and operating-cost inflation.
| Q3 2026 | Q3 2025 | Consensus / comparison | |
|---|---|---|---|
| Net sales (Financial Results) | $2,192M | $2,190M | ~$2,170M |
| Adjusted EPS (Adjusted Earnings Per Share) | $0.23 | $0.58 | ~$0.22 |
| Adjusted EBITDA (Adjusted EBITDA reconciliation) | $289M | $383M | ~$283M |
| Adjusted EBITDA margin (Adjusted EBITDA reconciliation) | 13.2% | 17.5% | — |
| Net leverage (Net Debt calculation) | 4.8x | 3.9x | 3.8x at Dec. 31, 2025 |
The quarter cleared the lowered earnings bar, but only narrowly. Adjusted EPS was slightly above the roughly $0.22 consensus and revenue beat the roughly $2.17 billion expectation, while adjusted EBITDA also came in above the roughly $283 million estimate. That makes the scorecard a beat, but not a clean operational win: the revenue outperformance was modest and largely reflected 1% volume/mix growth offset by lower pricing.
Underlying profitability remains the main problem. Adjusted EBITDA fell $94 million year over year, with $83 million of higher commodity and operating-cost inflation plus $15 million of unfavorable pricing overwhelming productivity benefits. The 13.2% adjusted margin was down from 17.5%, so the company is still defending earnings rather than demonstrating a durable margin recovery. 〔0〕
Cash generation improved, but leverage has not yet meaningfully reset. Year-to-date adjusted cash flow reached $314 million versus negative $332 million a year earlier, helped by sharply lower capital spending and working-capital movements. Net debt fell $148 million from year-end, but net leverage rose to 4.8x because the earnings base weakened; that leaves less room for execution mistakes even as the company says cost actions should support EBITDA growth in 2027.
Guidance was reaffirmed, not upgraded. The company kept its approximately $8.6 billion sales, $1.05 billion adjusted EBITDA and $0.65 adjusted EPS targets, along with $600 million to $700 million of adjusted cash flow. That supports the recovery narrative but does not raise the bar; the key test shifts to whether fourth-quarter pricing and productivity can offset inflation and begin restoring margins.
Bottom line: This was a narrow earnings beat against reduced expectations, supported by cash flow and cost actions, but the core business is still losing margin and carrying heavier leverage. The filing modestly advances the recovery story without proving that the recovery is durable.
Q4 pricing gains and 2027 EBITDA growth
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!